Nimodipine sustained-release tablets are calcium antagonists, used for cerebral vasospasm and sudden deafness caused by ischemic cerebrovascular disease, migraine, mild subarachnoid hemorrhage. It can reduce the pain of vascular, tension, cluster and mixed headaches, reduce the frequency of attacks, and prevent the appearance of aura symptoms.

The global Nimodipine Sustained Release Tablets market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nimodipine Sustained Release Tablets in various end use industries. The expanding demands from the Hospital, Pharmacy and Others,, are propelling Nimodipine Sustained Release Tablets market. 30mg/Piece, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 60mg/Piece segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Nimodipine Sustained Release Tablets market, driven by demand from China, the second largest economy with some signs of stabilising, the Nimodipine Sustained Release Tablets market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nimodipine Sustained Release Tablets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Nimodipine Sustained Release Tablets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Nimodipine Sustained Release Tablets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nimodipine Sustained Release Tablets sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Nimodipine Sustained Release Tablets covered in this report include Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International, Heritage Pharmaceuticals, Bayer Vital, Wuhan HITECK Biopharmaceutical, Qilu Pharmaceutical and Yabao Pharmaceutical Group, etc.

The global Nimodipine Sustained Release Tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Bionpharma

Arbor Pharmaceuticals

Sofgen Pharmaceuticals

Pharmaceutics International

Heritage Pharmaceuticals

Bayer Vital

Wuhan HITECK Biopharmaceutical

Qilu Pharmaceutical

Yabao Pharmaceutical Group

Sihuan Pharmaceutical

Jiangsu Kanion Pharmaceutical

Shandong Yunmen Pharmaceutical

Scope of Nimodipine Sustained Release Tablets - Market Report

Report Metric	Details
Report Name	Nimodipine Sustained Release Tablets - Market
Global Nimodipine Sustained Release Tablets market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nimodipine Sustained Release Tablets market, Segment by Type:	30mg/Piece 60mg/Piece Others
Global Nimodipine Sustained Release Tablets market, by Application	Hospital Pharmacy Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Nimodipine Sustained Release Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nimodipine Sustained Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Nimodipine Sustained Release Tablets - Market report?

Ans: The Applications covered in the Nimodipine Sustained Release Tablets - Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Nimodipine Sustained Release Tablets - Market report?

Ans: The Types covered in the Nimodipine Sustained Release Tablets - Market report are 30mg/Piece, 60mg/Piece, Others

1 Nimodipine Sustained Release Tablets Market Overview

1.1 Nimodipine Sustained Release Tablets Product Overview

1.2 Nimodipine Sustained Release Tablets Market Segment by Type

1.2.1 30mg/Piece

1.2.2 60mg/Piece

1.2.3 Others

1.3 Global Nimodipine Sustained Release Tablets Market Size by Type

1.3.1 Global Nimodipine Sustained Release Tablets Market Size Overview by Type (2018-2029)

1.3.2 Global Nimodipine Sustained Release Tablets Historic Market Size Review by Type (2018-2023)

1.3.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Nimodipine Sustained Release Tablets Sales Breakdown by Type (2018-2023)

1.4.2 Europe Nimodipine Sustained Release Tablets Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Nimodipine Sustained Release Tablets Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Nimodipine Sustained Release Tablets Sales Breakdown by Type (2018-2023)

2 Global Nimodipine Sustained Release Tablets Market Competition by Company

2.1 Global Top Players by Nimodipine Sustained Release Tablets Sales (2018-2023)

2.2 Global Top Players by Nimodipine Sustained Release Tablets Revenue (2018-2023)

2.3 Global Top Players by Nimodipine Sustained Release Tablets Price (2018-2023)

2.4 Global Top Manufacturers Nimodipine Sustained Release Tablets Manufacturing Base Distribution, Sales Area, Product Type

2.5 Nimodipine Sustained Release Tablets Market Competitive Situation and Trends

2.5.1 Nimodipine Sustained Release Tablets Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Nimodipine Sustained Release Tablets Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine Sustained Release Tablets as of 2022)

2.7 Date of Key Manufacturers Enter into Nimodipine Sustained Release Tablets Market

2.8 Key Manufacturers Nimodipine Sustained Release Tablets Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Nimodipine Sustained Release Tablets Status and Outlook by Region

3.1 Global Nimodipine Sustained Release Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Nimodipine Sustained Release Tablets Historic Market Size by Region

3.2.1 Global Nimodipine Sustained Release Tablets Sales in Volume by Region (2018-2023)

3.2.2 Global Nimodipine Sustained Release Tablets Sales in Value by Region (2018-2023)

3.2.3 Global Nimodipine Sustained Release Tablets Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Region

3.3.1 Global Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2029)

3.3.2 Global Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2029)

3.3.3 Global Nimodipine Sustained Release Tablets Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Nimodipine Sustained Release Tablets by Application

4.1 Nimodipine Sustained Release Tablets Market Segment by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.1.3 Others

4.2 Global Nimodipine Sustained Release Tablets Market Size by Application

4.2.1 Global Nimodipine Sustained Release Tablets Market Size Overview by Application (2018-2029)

4.2.2 Global Nimodipine Sustained Release Tablets Historic Market Size Review by Application (2018-2023)

4.2.3 Global Nimodipine Sustained Release Tablets Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Nimodipine Sustained Release Tablets Sales Breakdown by Application (2018-2023)

4.3.2 Europe Nimodipine Sustained Release Tablets Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Nimodipine Sustained Release Tablets Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Nimodipine Sustained Release Tablets Sales Breakdown by Application (2018-2023)

5 North America Nimodipine Sustained Release Tablets by Country

5.1 North America Nimodipine Sustained Release Tablets Historic Market Size by Country

5.1.1 North America Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Nimodipine Sustained Release Tablets Sales in Volume by Country (2018-2023)

5.1.3 North America Nimodipine Sustained Release Tablets Sales in Value by Country (2018-2023)

5.2 North America Nimodipine Sustained Release Tablets Forecasted Market Size by Country

5.2.1 North America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2029)

5.2.2 North America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2029)

6 Europe Nimodipine Sustained Release Tablets by Country

6.1 Europe Nimodipine Sustained Release Tablets Historic Market Size by Country

6.1.1 Europe Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Nimodipine Sustained Release Tablets Sales in Volume by Country (2018-2023)

6.1.3 Europe Nimodipine Sustained Release Tablets Sales in Value by Country (2018-2023)

6.2 Europe Nimodipine Sustained Release Tablets Forecasted Market Size by Country

6.2.1 Europe Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2029)

6.2.2 Europe Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2029)

7 Asia-Pacific Nimodipine Sustained Release Tablets by Region

7.1 Asia-Pacific Nimodipine Sustained Release Tablets Historic Market Size by Region

7.1.1 Asia-Pacific Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Nimodipine Sustained Release Tablets Forecasted Market Size by Region

7.2.1 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Nimodipine Sustained Release Tablets Sales in Value by Region (2024-2029)

8 Latin America Nimodipine Sustained Release Tablets by Country

8.1 Latin America Nimodipine Sustained Release Tablets Historic Market Size by Country

8.1.1 Latin America Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Nimodipine Sustained Release Tablets Sales in Volume by Country (2018-2023)

8.1.3 Latin America Nimodipine Sustained Release Tablets Sales in Value by Country (2018-2023)

8.2 Latin America Nimodipine Sustained Release Tablets Forecasted Market Size by Country

8.2.1 Latin America Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2029)

8.2.2 Latin America Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2029)

9 Middle East and Africa Nimodipine Sustained Release Tablets by Country

9.1 Middle East and Africa Nimodipine Sustained Release Tablets Historic Market Size by Country

9.1.1 Middle East and Africa Nimodipine Sustained Release Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Nimodipine Sustained Release Tablets Forecasted Market Size by Country

9.2.1 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Nimodipine Sustained Release Tablets Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Bionpharma

10.1.1 Bionpharma Company Information

10.1.2 Bionpharma Introduction and Business Overview

10.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Bionpharma Nimodipine Sustained Release Tablets Products Offered

10.1.5 Bionpharma Recent Development

10.2 Arbor Pharmaceuticals

10.2.1 Arbor Pharmaceuticals Company Information

10.2.2 Arbor Pharmaceuticals Introduction and Business Overview

10.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered

10.2.5 Arbor Pharmaceuticals Recent Development

10.3 Sofgen Pharmaceuticals

10.3.1 Sofgen Pharmaceuticals Company Information

10.3.2 Sofgen Pharmaceuticals Introduction and Business Overview

10.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered

10.3.5 Sofgen Pharmaceuticals Recent Development

10.4 Pharmaceutics International

10.4.1 Pharmaceutics International Company Information

10.4.2 Pharmaceutics International Introduction and Business Overview

10.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Pharmaceutics International Nimodipine Sustained Release Tablets Products Offered

10.4.5 Pharmaceutics International Recent Development

10.5 Heritage Pharmaceuticals

10.5.1 Heritage Pharmaceuticals Company Information

10.5.2 Heritage Pharmaceuticals Introduction and Business Overview

10.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Products Offered

10.5.5 Heritage Pharmaceuticals Recent Development

10.6 Bayer Vital

10.6.1 Bayer Vital Company Information

10.6.2 Bayer Vital Introduction and Business Overview

10.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Bayer Vital Nimodipine Sustained Release Tablets Products Offered

10.6.5 Bayer Vital Recent Development

10.7 Wuhan HITECK Biopharmaceutical

10.7.1 Wuhan HITECK Biopharmaceutical Company Information

10.7.2 Wuhan HITECK Biopharmaceutical Introduction and Business Overview

10.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Products Offered

10.7.5 Wuhan HITECK Biopharmaceutical Recent Development

10.8 Qilu Pharmaceutical

10.8.1 Qilu Pharmaceutical Company Information

10.8.2 Qilu Pharmaceutical Introduction and Business Overview

10.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Products Offered

10.8.5 Qilu Pharmaceutical Recent Development

10.9 Yabao Pharmaceutical Group

10.9.1 Yabao Pharmaceutical Group Company Information

10.9.2 Yabao Pharmaceutical Group Introduction and Business Overview

10.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Products Offered

10.9.5 Yabao Pharmaceutical Group Recent Development

10.10 Sihuan Pharmaceutical

10.10.1 Sihuan Pharmaceutical Company Information

10.10.2 Sihuan Pharmaceutical Introduction and Business Overview

10.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Products Offered

10.10.5 Sihuan Pharmaceutical Recent Development

10.11 Jiangsu Kanion Pharmaceutical

10.11.1 Jiangsu Kanion Pharmaceutical Company Information

10.11.2 Jiangsu Kanion Pharmaceutical Introduction and Business Overview

10.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Products Offered

10.11.5 Jiangsu Kanion Pharmaceutical Recent Development

10.12 Shandong Yunmen Pharmaceutical

10.12.1 Shandong Yunmen Pharmaceutical Company Information

10.12.2 Shandong Yunmen Pharmaceutical Introduction and Business Overview

10.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Products Offered

10.12.5 Shandong Yunmen Pharmaceutical Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Nimodipine Sustained Release Tablets Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Nimodipine Sustained Release Tablets Industrial Chain Analysis

11.4 Nimodipine Sustained Release Tablets Market Dynamics

11.4.1 Nimodipine Sustained Release Tablets Industry Trends

11.4.2 Nimodipine Sustained Release Tablets Market Drivers

11.4.3 Nimodipine Sustained Release Tablets Market Challenges

11.4.4 Nimodipine Sustained Release Tablets Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Nimodipine Sustained Release Tablets Distributors

12.3 Nimodipine Sustained Release Tablets Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Bionpharma

Arbor Pharmaceuticals

SOFGEN PHARMACEUTICALS

Pharmaceutics International

Heritage Pharmaceuticals

Bayer Vital

Wuhan HITECK Biopharmaceutical

Qilu Pharmaceutical

Yabao Pharmaceutical Group

Sihuan Pharmaceutical

Jiangsu Kanion Pharmaceutical

Shandong Yunmen Pharmaceutical

List of Tables

Table 1. Major Company of 30mg/Piece

Table 2. Major Company of 60mg/Piece

Table 3. Major Company of Others

Table 4. Global Nimodipine Sustained Release Tablets Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 5. Global Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (K Units)

Table 6. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type (2018-2023)

Table 7. Global Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US& Million)

Table 8. Global Nimodipine Sustained Release Tablets Market Share in Value by Type (2018-2023)

Table 9. Global Nimodipine Sustained Release Tablets Price by Type (2018-2023) & (USD/Unit)

Table 10. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2029) & (K Units)

Table 11. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type (2024-2029)

Table 12. Global Nimodipine Sustained Release Tablets Sales by Type (2024-2029) & (US$ Million)

Table 13. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Type (2024-2029)

Table 14. Global Nimodipine Sustained Release Tablets Price by Type (2024-2029) & (USD/Unit)

Table 15. North America Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (K Units)

Table 16. North America Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US$ Million)

Table 17. Europe Nimodipine Sustained Release Tablets Sales (K Units) by Type (2018-2023)

Table 18. Europe Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US$ Million)

Table 19. Asia-Pacific Nimodipine Sustained Release Tablets Sales (K Units) by Type (2018-2023)

Table 20. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US$ Million)

Table 21. Latin America Nimodipine Sustained Release Tablets Sales (K Units) by Type (2018-2023)

Table 22. Latin America Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US$ Million)

Table 23. Middle East and Africa Nimodipine Sustained Release Tablets Sales (K Units) by Type (2018-2023)

Table 24. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Type (2018-2023) & (US$ Million)

Table 25. Global Nimodipine Sustained Release Tablets Sales by Company (2018-2023) & (K Units)

Table 26. Global Nimodipine Sustained Release Tablets Sales Share by Company (2018-2023)

Table 27. Global Nimodipine Sustained Release Tablets Revenue by Company (2018-2023) & (US$ Million)

Table 28. Global Nimodipine Sustained Release Tablets Revenue Share by Company (2018-2023)

Table 29. Global Market Nimodipine Sustained Release Tablets Price by Company (2018-2023) & (USD/Unit)

Table 30. Global Nimodipine Sustained Release Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 31. Global Nimodipine Sustained Release Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nimodipine Sustained Release Tablets as of 2022)

Table 33. Date of Key Manufacturers Enter into Nimodipine Sustained Release Tablets Market

Table 34. Key Manufacturers Nimodipine Sustained Release Tablets Product Type

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Nimodipine Sustained Release Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 37. Global Nimodipine Sustained Release Tablets Sales by Region (2018-2023) & (K Units)

Table 38. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2018-2023)

Table 39. Global Nimodipine Sustained Release Tablets Sales by Region (2018-2023) & (US$ Million)

Table 40. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2018-2023)

Table 41. Global Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 42. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2029) & (K Units)

Table 43. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2029)

Table 44. Global Nimodipine Sustained Release Tablets Sales by Region (2024-2029) & (US$ Million)

Table 45. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2029)

Table 46. Global Nimodipine Sustained Release Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)

Table 47. Global Nimodipine Sustained Release Tablets Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 48. Global Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (K Units)

Table 49. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application (2018-2023)

Table 50. Global Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 51. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Application (2018-2023)

Table 52. Global Nimodipine Sustained Release Tablets Price by Application (2018-2023) & (USD/Unit)

Table 53. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2029) & (K Units)

Table 54. Global Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application (2024-2029)

Table 55. Global Nimodipine Sustained Release Tablets Sales by Application (2024-2029) & (US$ Million)

Table 56. Global Nimodipine Sustained Release Tablets Sales Market Share in Value by Application (2024-2029)

Table 57. Global Nimodipine Sustained Release Tablets Price by Application (2024-2029) & (USD/Unit)

Table 58. North America Nimodipine Sustained Release Tablets Sales by Application (2018-2023) (K Units)

Table 59. North America Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 60. Europe Nimodipine Sustained Release Tablets Sales by Application (2018-2023) (K Units)

Table 61. Europe Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 62. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Application (2018-2023) (K Units)

Table 63. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 64. Latin America Nimodipine Sustained Release Tablets Sales by Application (2018-2023) (K Units)

Table 65. Latin America Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 66. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Application (2018-2023) (K Units)

Table 67. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Application (2018-2023) & (US$ Million)

Table 68. North America Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (K Units)

Table 69. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2018-2023)

Table 70. North America Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (US$ Million)

Table 71. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2018-2023)

Table 72. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (K Units)

Table 73. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2029)

Table 74. North America Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (US$ Million)

Table 75. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2029)

Table 76. Europe Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (K Units)

Table 77. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2018-2023)

Table 78. Europe Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (US$ Million)

Table 79. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2018-2023)

Table 80. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (K Units)

Table 81. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2029)

Table 82. Europe Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (US$ Million)

Table 83. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2029)

Table 84. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2018-2023) & (K Units)

Table 85. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2018-2023)

Table 86. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2018-2023) & (US$ Million)

Table 87. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2018-2023)

Table 88. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2029) & (K Units)

Table 89. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Region (2024-2029)

Table 90. Asia-Pacific Nimodipine Sustained Release Tablets Sales by Region (2024-2029) & (US$ Million)

Table 91. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Region (2024-2029)

Table 92. Latin America Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (K Units)

Table 93. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2018-2023)

Table 94. Latin America Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (US$ Million)

Table 95. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2018-2023)

Table 96. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (K Units)

Table 97. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2029)

Table 98. Latin America Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (US$ Million)

Table 99. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2029)

Table 100. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (K Units)

Table 101. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2018-2023)

Table 102. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2018-2023) & (US$ Million)

Table 103. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2018-2023)

Table 104. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (K Units)

Table 105. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Country (2024-2029)

Table 106. Middle East and Africa Nimodipine Sustained Release Tablets Sales by Country (2024-2029) & (US$ Million)

Table 107. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Country (2024-2029)

Table 108. Bionpharma Company Information

Table 109. Bionpharma Introduction and Business Overview

Table 110. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 111. Bionpharma Nimodipine Sustained Release Tablets Product

Table 112. Bionpharma Recent Development

Table 113. Arbor Pharmaceuticals Company Information

Table 114. Arbor Pharmaceuticals Introduction and Business Overview

Table 115. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 116. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 117. Arbor Pharmaceuticals Recent Development

Table 118. Sofgen Pharmaceuticals Company Information

Table 119. Sofgen Pharmaceuticals Introduction and Business Overview

Table 120. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 121. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 122. Sofgen Pharmaceuticals Recent Development

Table 123. Pharmaceutics International Company Information

Table 124. Pharmaceutics International Introduction and Business Overview

Table 125. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 126. Pharmaceutics International Nimodipine Sustained Release Tablets Product

Table 127. Pharmaceutics International Recent Development

Table 128. Heritage Pharmaceuticals Company Information

Table 129. Heritage Pharmaceuticals Introduction and Business Overview

Table 130. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 131. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product

Table 132. Heritage Pharmaceuticals Recent Development

Table 133. Bayer Vital Company Information

Table 134. Bayer Vital Introduction and Business Overview

Table 135. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 136. Bayer Vital Nimodipine Sustained Release Tablets Product

Table 137. Bayer Vital Recent Development

Table 138. Wuhan HITECK Biopharmaceutical Company Information

Table 139. Wuhan HITECK Biopharmaceutical Introduction and Business Overview

Table 140. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 141. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product

Table 142. Wuhan HITECK Biopharmaceutical Recent Development

Table 143. Qilu Pharmaceutical Company Information

Table 144. Qilu Pharmaceutical Introduction and Business Overview

Table 145. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 146. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 147. Qilu Pharmaceutical Recent Development

Table 148. Yabao Pharmaceutical Group Company Information

Table 149. Yabao Pharmaceutical Group Introduction and Business Overview

Table 150. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 151. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product

Table 152. Yabao Pharmaceutical Group Recent Development

Table 153. Sihuan Pharmaceutical Company Information

Table 154. Sihuan Pharmaceutical Introduction and Business Overview

Table 155. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 156. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 157. Sihuan Pharmaceutical Recent Development

Table 158. Jiangsu Kanion Pharmaceutical Company Information

Table 159. Jiangsu Kanion Pharmaceutical Introduction and Business Overview

Table 160. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 161. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 162. Jiangsu Kanion Pharmaceutical Recent Development

Table 163. Shandong Yunmen Pharmaceutical Company Information

Table 164. Shandong Yunmen Pharmaceutical Introduction and Business Overview

Table 165. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)

Table 166. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product

Table 167. Shandong Yunmen Pharmaceutical Recent Development

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. Nimodipine Sustained Release Tablets Market Trends

Table 171. Nimodipine Sustained Release Tablets Market Drivers

Table 172. Nimodipine Sustained Release Tablets Market Challenges

Table 173. Nimodipine Sustained Release Tablets Market Restraints

Table 174. Nimodipine Sustained Release Tablets Distributors List

Table 175. Nimodipine Sustained Release Tablets Downstream Customers

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Nimodipine Sustained Release Tablets Product Picture

Figure 2. Global Nimodipine Sustained Release Tablets Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Nimodipine Sustained Release Tablets Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Nimodipine Sustained Release Tablets Sales Status and Outlook (2018-2029) & (K Units)

Figure 5. Product Picture of 30mg/Piece

Figure 6. Global 30mg/Piece Sales YoY Growth (2018-2029) & (K Units)

Figure 7. Product Picture of 60mg/Piece

Figure 8. Global 60mg/Piece Sales YoY Growth (2018-2029) & (K Units)

Figure 9. Product Picture of Others

Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 11. Global Nimodipine Sustained Release Tablets Sales by Type (2018-2029) & (US$ Million)

Figure 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Type in 2022 & 2029

Figure 13. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022

Figure 14. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022

Figure 15. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022

Figure 16. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022

Figure 17. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022

Figure 18. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022

Figure 19. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022

Figure 20. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022

Figure 21. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Volume by Type in 2022

Figure 22. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Type in 2022

Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine Sustained Release Tablets Sales in 2022

Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Nimodipine Sustained Release Tablets Revenue in 2022

Figure 25. Nimodipine Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 26. Product Picture of Hospital

Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)

Figure 28. Product Picture of Pharmacy

Figure 29. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)

Figure 30. Product Picture of Others

Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)

Figure 32. Global Nimodipine Sustained Release Tablets Sales by Application (2018-2029) & (US$ Million)

Figure 33. Global Nimodipine Sustained Release Tablets Sales Market Share by Application in 2022 & 2029

Figure 34. North America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022

Figure 35. North America Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022

Figure 36. Europe Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022

Figure 37. Europe Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022

Figure 38. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022

Figure 39. Asia-Pacific Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022

Figure 40. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Volume by Application in 2022

Figure 41. Latin America Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022

Figure 42. Middle East and Africa Nimodipine Sustained Release Tablets Sales Market Share in Value by Application in 2022

Figure 43. Key Raw Materials Price

Figure 44. Nimodipine Sustained Release Tablets Manufacturing Cost Structure

Figure 45. Nimodipine Sustained Release Tablets Industrial Chain Analysis

Figure 46. Channels of Distribution

Figure 47. Distributors Profiles

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Oral OTC Analgesics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16Y2908

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Dysthymia Clinical Trial Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2P6528

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions